Two New Clinical Studies Demonstrate Accuracy of Viz.ai Algorithm for Intracranial Hemorrhage Volume Measurements to Advance Timely, Critical Treatment Decisions [Yahoo! Finance]
Geron Corporation (GERN)
Last geron corporation earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
geron.com/investors
Company Research
Source: Yahoo! Finance
SAN FRANCISCO, April 23, 2025 BUSINESS WIRE )--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data validating the accuracy and clinical utility of its AI-powered hyperdensity measurement solution for intracranial hemorrhage (ICH) management. Two independent studies highlight the ability of Viz ICH Plus to accurately and efficiently measure hemorrhage volume, quantify lateral ventricular volume, and estimate midline shift. "Patients with ICH often require multiple scans in a short timeframe to guide treatment decisions," said Peter Kan, MD, MPH, FRCSC, FAANS, Professor and Chair, Department of Neurosurgery, University of Texas Medical Branch. "Manual measurements can be time-consuming and vary between providers. Viz ICH Plus enables us to assess patients more quickly, identify the most urgent cases, and determine whether intervention is needed—with greater consistency and efficiency." The first study published in
Show less
Read more
Impact Snapshot
Event Time:
GERN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GERN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GERN alerts
High impacting Geron Corporation news events
Weekly update
A roundup of the hottest topics
GERN
News
- Geron Corporation (GERN) Presents New Data at the 67th American Society of Hematology 2025 Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On The Sidelines [Seeking Alpha]Seeking Alpha
- Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation [Yahoo! Finance]Yahoo! Finance
- Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value CreationGlobeNewswire
- Geron (NASDAQ:GERN) had its "neutral" rating reaffirmed by analysts at HC Wainwright.MarketBeat
GERN
Earnings
- 11/5/25 - In-Line
GERN
Sec Filings
- 12/15/25 - Form 144
- 11/7/25 - Form 10-Q
- 11/5/25 - Form 8-K
- GERN's page on the SEC website